Skip to content

Effect of sufentanil combined with dexketoprofen tromethamine in postoperative patient-controlled intravenous analgesia in patients undergoing thoracoscopic surgery

Effect of sufentanil combined with dexketoprofen tromethamine in postoperative patient-controlled intravenous analgesia in patients undergoing thoracoscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087079
Enrollment
Unknown
Registered
2024-07-19
Start date
2024-07-20
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Group S:Postoperative analgesia pump use: 2 µg/kg + 10 mg of tropisetron + 0.9% saline to 100 mL
Group R:Postoperative analgesia pump use: 2 µg/kg + dexketoprofen tromethamine 300 mg + tropisetron 10 mg + 0.9% saline to 100 mL

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All patients were informed of the study and signed the consent form; 2. All had no contraindications to postoperative PCA and dexketoprofen use; 3. All were grade I to III according to the grading standards of the American Society of Anesthesiologists (SAS); 4. No coagulation dysfunction; 5.The subjects understand and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to the drugs used in this study; 2. Patients with severe disorders of important organs such as the heart, liver, and kidneys; 3. Patients with airway hyperresponsiveness; 4. Pregnant, lactating, or women who are preparing for pregnancy or whose spouses are preparing for pregnancy; 5. Patients who are currently participating in other clinical trials; 6. Patients who are considered by the researchers to be unsuitable for this trial.

Design outcomes

Primary

MeasureTime frame
Cumulative consumption of patient-controlled intravenous analgesia (PCIA) in the 48 hours after surgery;

Secondary

MeasureTime frame
Visual analogue scale (VAS) scores immediately after awakening and at 6, 12, 24, and 48 hours after surgery;PCA single dose number;Effective compression rate of the patient's intravenous patient-controlled analgesia pump 48 hours after surgery (effective compression times/total compression times);Adverse reactions within 48 hours after surgery (respiratory depression, nausea and vomiting, itching, urinary retention, etc.);

Countries

China

Contacts

Public ContactXinlei Lu

Hangzhou First People's Hospital

mazuiluxinlei@163.com+86 176 8195 7300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026